(UroToday.com) Dr. Surena Matin presented the final results of the OLYMPUS trial, Optimized DeLivery of Mitomycin for Primary UTUC Study (Olympus) at the Best of Bladder Cancer poster session.
(UroToday.com) During the first testicular cancer session at the 2020 Annual Meeting of the Society of Urologic Oncology, Dr. Clint Cary tackled management of one of the rarest and difficult patient populations in urologic oncology: those with late recurrence or relapse of testicular cancer.
(UroToday.com) Dr. Ardeshir Rastinehad gave a summarized overview of the ongoing clinical trial of focal therapy in prostate cancer.
(UroToday.com) At this year’s Society of Urologic Oncology (SUO) virtual annual meeting, Dr. Leibovich gave an overview of the different elements that should be considered when treating patients with bilateral renal cell carcinoma (RCC).
(UroToday.com) Dr. Shane Wells began the kidney cancer session by giving an update on the most recent renal complex cyst classification.
(UroToday.com) At the Society of Urologic Oncology (SUO) virtual annual meeting, Dr. James Wysock gave an update on the use of imaging in primary prostate cancer diagnosis. The PROMIS trial demonstrated that the use of multi-parametric MRI (mpMRI) improved sensitivity by 93% compared to transrectal ultrasound (TRUS), which has a sensitivity of only 48%1. The PRECISION […]
(UroToday.com) In this discussion, Dr. Jones gave an overview of racial disparities through healthcare workforce diversity. There are significant racial disparities occurring in healthcare, and the Institute of Medicine report recommends increasing the underrepresented minority groups in the healthcare workforce1. Table 1 demonstrates the diversity in healthcare providers in 2018, showing significant disparities.
(UroToday.com) In this presentation, Dr. Arjun Sivaraman discussed the outcomes of focal therapy in prostate cancer. The rationale for focal therapy in carefully selected patients is the complete ablation of the cancerous lesions with a safety margin and preservation of non-cancerous tissue, with minimal adverse events.
(UroToday.com) In this presentation, Dr. Minhaj Siddiqui elaborated on whether there is a role for biomarkers in the selection of patients for focal therapy. To date, there have been no biomarkers designed for this purpose. Dr. Siddiqui believes that in select, as of yet unclear clinical scenarios, biomarkers may hold a significant benefit. Figure 1 demonstrates […]
(UroToday.com) Medicaid expansion was a core tenet of the Affordable Care Act (ACA), aimed at increasing coverage for low-income individuals. Medicaid expansion was undertaken at a state-level with some opting in and others electing not to participate. In a session of the Best Poster Presentations in Health Services and Other Research at this year’s Society of Urologic Oncology […]
